In addition, previous study investigated the effects of evodiamine on human pancreatic cancer cell, and the results indicated that evodiamine-induced pancreatic cancer cell apoptosis by inhibiting PI3K/AKT and mitogen-activated protein kinase/ERK [29]. Here, WNK2 is linked to familial pancreatic carcinoma.